News | April 27, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The company allocated €56 million to research and development for next-generation line solutions
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
